OPK OPKO Health, Inc. Earnings per share growth rate in current year

The stable operation of OPKO Health, Inc. (OPK) automated laboratories and facilities guarantees uninterrupted product output. Diversification between pharmacology and diagnostics ensures a steady cash flow, offsetting innovation expenses. This annual EPS growth chart demonstrates profit dynamics, with 28.00 becoming the new value for this metric. Business scalability relies on patent protection and a network of centers, allowing for the replication of high-margin tests.

OPKO Health - OPK Earnings per share growth in current year (period 07/04/2022 - 11/15/2026)

Comprehensive metric breakdowns and analytics for OPKO Health (OPK)

- current quotes and average value forecast:

Market Chart OPKO Health Corp.|OPK - Price Target Chart

- market capitalization data:

Market Value OPKO Health, Inc.|OPK - Total Company Value

- balance sheet equity data:

Share Book Value OPKO Health|OPK - Company Book Value|Market Capitalization to Book Value Ratio opko.com|OPK - Aggregate Company Assets

- debt and liquidity details:

- financial results and valuation multiples details:

OPK - Company Net Income|Expected Profit OPKO Health, Inc.|OPK - Price to Earnings Ratio|Market Cap to Future Earnings Ratio OPKO Health, Inc.|OPK - PEG Multiple|Business Value to Operating Income Before Depreciation OPKO Health Inc|OPK - Operating profit before deduction of amortization|Earnings per share for the trailing year OPKO Health|OPK - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months opko.com|OPK - Earnings per share growth in current year|Projected earnings per share growth rate for next year OPKO Health, Inc.

- revenue and sales proceeds data:

OPK - Revenue and Sales Volume|Company Future Sales Volume OPKO Health, Inc.|OPK - Market Cap to Revenue|Market Cap to Expected Sales Ratio OPKO Health, Inc.|OPK - Sales Growth YoY (Last Twelve Months)

Fundamental valuation:OPKO Corp (OPK)

This indicator measures the year-over-year dynamics of earnings per share, allowing investors to filter out price volatility and assess the actual efficiency of capital generation. By analyzing the annual EPS variance in percentage terms, one can determine how effectively OPKO Health, Inc. (OPK) has optimized its biomaterial logistics and reagent procurement costs within its standardized medical outsourcing model.

Direct competitors